NAD-based inhibitors with anticancer potential

Krzysztof Felczak, Robert Vince, Krzysztof W. Pankiewicz

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Three classes of novel inhibitors of inosine monophosphate dehydrogenase have been prepared and their anti-proliferative properties were evaluated against several cancer cell lines. (1) Mycophenolic adenine dinucleotide analogues (8-13) containing a substituent at the C2 of adenine ring were found to be potent inhibitors of IMPDH (Ki's in range of 0.6-82 nM) and sub-μM inhibitors of leukemic K562 cell proliferation. (2) Mycophenolic adenosine (d and l) esters (20 and 21) showed a potent inhibition of IMPDH2 (Ki = 102 and Ki = 231 nM, respectively) and inhibition of K562 cell growth (IC50 = 0.5 and IC50 = 1.6 μM). These compounds serve both as inhibitors of the enzyme and as a depot form of mycophenolic acid. The corresponding amide analogue 22, also a potent inhibitor of IMPDH (Ki = 84 nM), did not inhibit cancer cell proliferation. (3) Mycophenolic-(l)-and (d)-valine adenine di-amide derivatives 25 (Ki = 9 nM) and 28 (Ki = 3 nM) were found to be very potent enzymatically, but did not inhibit proliferation of cancer cells.

Original languageEnglish (US)
Pages (from-to)332-336
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Issue number1
StatePublished - Jan 1 2014


  • Inosine monophosphate dehydrogenase
  • Mycophenolic acid
  • Mycophenolic adenine dinucleotides
  • Nicotinamide adenine dinucleotide
  • Novel IMPDH inhibitors


Dive into the research topics of 'NAD-based inhibitors with anticancer potential'. Together they form a unique fingerprint.

Cite this